Skip to content
Search

Latest Stories

Alison Jones joins PDA as stakeholder engagement director

The Pharmacists Defence Association (PDA) has appointed Alison Jones as the director of stakeholder engagement.

She will also manage the PDA's policy department until a permanent director of policy is appointed, the PDA said in a press release.


Jones previously served as government affairs manager at McKesson UK, having worked for Lloyds Pharmacy, and the wider Celesio/McKesson group since 2003.

“This new role will enhance the PDA’s work, ensuring the voices and interests of individual pharmacists are heard throughout decision making in the sector, the health system and beyond, across the UK,” the association said.

“I am delighted to be joining the PDA in this exciting new role,” said Jones. “My main objective will be to positively support and promote the interests of employed and locum pharmacists working in all settings across the UK.

"I will be looking at emerging policies and working with colleagues and members to develop stakeholder campaigns which address important issues affecting individual pharmacists and ensuring that opportunities are fully explored.”

Mark Koziol, the PDA chair, added: “I am delighted to welcome Alison into the leadership team in an important new role to our structure. The positive influence that pharmacists can have through the PDA grows as our membership numbers continue to increase and as we do more and more as a Defence Association, an Independent Trade Union and as part of Equality, Diversity and Inclusion Networks. I am sure Alison will be an asset to an already strong team.”

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less